Skip to content
S4424Senate2009-2010 SessionSame asA6127

Establishes corporate franchise tax credit for uncollected prescription co-payments

Sponsor Owen H. JohnsonSD-4Affects Legal
Status
In Senate Committee
Investigations And Government Operations
Impact
Pending
Passage
Pending

Bill progress

Step 2 of 7

In committee · Investigations And Government Operations

What's happening

Writing a plain-English summary… Track this bill to get it by email.

Why it matters

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Who cares

Headline styles

Sponsors

Primary sponsor
Owen H. Johnson

Senator · Senate District 4

No co-sponsors yet.

History

  1. Referred to investigations and government operations
  2. Referred to investigations and government operations

Companion bill

The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.

A6127Assembly

Establishes corporate franchise tax credit for uncollected prescription co-payments

In Assembly Committee · Ways And Means · Sponsor Robin Schimminger

Full text

The text isn't available here yet. Check nysenate.gov.

Sponsor's memo

Title of bill

An act to amend the tax law, in relation to establishing an uncollected prescription drug co-payment corporate franchise tax credit

Purpose

Establishes a corporate franchise tax credit for uncollected prescription drug co-payments.

Summary of provisions

Section 1 creates a new subdivision 14 within section 210 of the Tax Law.

Section 2 effective date.

Justification

Under the Cuomo administration, New York State instituted a Medicaid co-payment for all medical benefits. Co-payments for prescription drugs were implemented by the Department of Social Services in 1995 and it was made clear to Medicaid beneficiaries that they could not be denied services if they could not afford the co-payment. As a result, pharmacies in the State of New York experienced a financial loss because 20% of the co-payments were not paid by the Medicaid beneficiaries. With the implementation of Medicaid Managed Care, the Department of Health no longer required a co-payment for prescription drugs for those beneficiaries that moved to Medicaid Managed Care. However, the co-payment remains on non-managed care Medicaid recipients.

Unlike hospitals, which are able to receive funding from bad debt and charity pools, pharmacies cannot write off their bad debt. Besides, pharmacies are not responsible for increasing costs and volume of prescription drugs.

Legislative history

1999/2000 - A.7313/S.4232: 2001-2002 A.4365-A/S.2568A: 2003/2004: A.1983/S.1043: 2005-2006 A.5458A/S.1995A: 2007-2008 A.3804A/S.1286A

Fiscal implications

Minimal to State.

Local fiscal implications

None.

Effective date

This act shall take effect January 1, 2010 and shall apply to taxable years commencing on and after such date.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.